Your browser doesn't support javascript.
loading
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
Lamarca, Angela; Santos-Laso, Alvaro; Utpatel, Kirsten; La Casta, Adelaida; Stock, Simone; Forner, Alejandro; Adeva, Jorge; Folseraas, Trine; Fabris, Luca; Macias, Rocio I R; Krawczyk, Marcin; Krawczyk, Marek; Cardinale, Vincenzo; Braconi, Chiara; Alvaro, Domenico; Evert, Matthias; Banales, Jesus M; Valle, Juan W.
Afiliação
  • Lamarca A; Medical Oncology/Institute of Cancer Sciences, The Christie NHS Foundation Trust/University of Manchester, Manchester, United Kingdom.
  • Santos-Laso A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Utpatel K; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • La Casta A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Stock S; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Forner A; BCLC group, Liver Unit, Hospital Clínic Barcelona, Barcelona, Spain.
  • Adeva J; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), The National Institute of Health Carlos III, Madrid, Spain.
  • Folseraas T; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Fabris L; 7Section of Gastroenterology and the Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
  • Macias RIR; Department of Molecular Medicine, University of Padua, Padua, Italy.
  • Krawczyk M; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), The National Institute of Health Carlos III, Madrid, Spain.
  • Krawczyk M; Experimental Hepatology and Drug Targeting (HEVEPHARM) group, University of Salamanca, IBSAL, Salamanca, Spain.
  • Cardinale V; Department of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany.
  • Braconi C; Laboratory of Metabolic Liver Diseases, Centre for Preclinical Research, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
  • Alvaro D; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
  • Evert M; Gastroenterology, Sapienza University of Rome, Rome, Italy.
  • Banales JM; Medical Oncology, The University of Glasgow, Glasgow, United Kingdom.
  • Valle JW; Gastroenterology, Sapienza University of Rome, Rome, Italy.
Hepatology ; 73(6): 2311-2325, 2021 06.
Article em En | MEDLINE | ID: mdl-33073396
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Neoplasias Hepáticas / Estadiamento de Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Neoplasias Hepáticas / Estadiamento de Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido